A team at the Korea Research Institute of Chemical Technology has synthesized tetrahydroisoquinoline- or isoindoline-substituted [1,2,4]triazolo[1,5- a ]pyridine derivatives acting as tyrosine-protein kinase JAK1 inhibitors.